Cardinal Health defeats lawsuit seeking to enjoin Asset Purchase Agreement relating to cancer diagnostic product
Clients Cardinal Health, Inc.
Jones Day successfully defended Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., against a lawsuit filed by Beijing Sinotau Medical Research Company, which sought to enjoin Navidea Biopharmaceuticals and Cardinal Health 414 from closing an Asset Purchase Agreement transferring the intellectual property rights of a radioactive cancer diagnostic product known as Lymphoseek from Navidea to Cardinal Health. The deal closed on schedule.
Beijing Sinotau Medical Research Co., Ltd. v. Navidea Biopharmaceuticals, Inc., et al., No. 17-00110 (D. Del.); No. 17-cv-00603 (S.D. Ohio)